In Nov 2010 it was announced that dosing of the first of its 150...

In Nov 2010 it was announced that dosing of the first of its 150 paediatric patients has commenced in Rawanda.This was the first of 4 sites. Now in July the announcement was made that 50 had been treated in Rwanda and a further 50 were being recruited in Burkina Faso.

As the Phase III tests is all about trialling and proof of product I am at a loss to understand the apparant lack of urgency shown by our testing partners. The loss of Mr Calvin Ross has had a greater impact than was ever envisaged.Surely they can provide EMS Management with a time line against which EMS can measure progress.

OR

Is it time to think about finding a new testing partner or are we to closely joined at the hip???

I will be staggered if the Q3 expectation is met.